Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.375SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.639SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.258.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.258.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
FB.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.25SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BK.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.21SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.11.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EE.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.4.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.76SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CK.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.6.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.75.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.40SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DM.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.60SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.49SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CK.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.9.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDK.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.49.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.3.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.44SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.6.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5 (Omicron)SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LZ.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KW.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KU.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used